Venrock Healthcare Capital Partners III, L.P., 10% Owner at Lycia Therapeutics, Inc. (LYCA), bought 8,305 shares at $26.95 ($224K) on 2026-11-02, disclosed to the SEC on 2026-11-04.
Open-market purchase of $224k LYCA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.